Institution
Seoul National University Hospital
Also known as: 서울대병원 · 서울대학교병원 · SNUH
- 736running trials
- 367closed trials
- 1researcher
- 45,140publications (OpenAlex)
Researchers
Running trials
Not yet recruiting
Enrolling by invitation
A Global Phase 2 Extension Study of Brogidirsen in Boys With Duchenne Muscular Dystrophy
Not yet recruiting
Not yet recruiting
COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"
Not yet recruiting
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Not yet recruiting
Niacin and Selenium Combination Therapy in Patients With Septic Shock
Not yet recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Edoxaban Versus Apixaban in Cancer-Associated Venous Thromboembolism
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
CD19 CAR-T Therapy for Refractory Childhood-Onset Systemic Lupus Erythematosus
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Autologous Adipose-Derived Stem Cell Injections for Knee Osteoarthritis
Recruiting
Recruiting
Not yet recruiting
Recruiting
SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors
Not yet recruiting
Recruiting
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
Recruiting
Recruiting
Recruiting
Lutetium (177Lu) DGUL Combined With Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer
Not yet recruiting
Recruiting
Recruiting
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Not yet recruiting
A Phase 3 Study of Viloxazine ER Capsules in Korean Children and Adolescents With ADHD
Recruiting
Recruiting
Recruiting
Recruiting
A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Showing 50 of 736.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer43 recruiting
- Colorectal cancer32 recruiting
- Liver and biliary tract cancer28 recruiting
- Ovarian cancer25 recruiting
- Childhood cancers22 recruiting
- Metastatic breast cancer19 recruiting
- Pancreatic cancer19 recruiting
- Gastric and oesophageal cancer18 recruiting
- Multiple myeloma17 recruiting
- Bladder cancer15 recruiting
- Coronary artery disease15 recruiting
- Crohn's disease14 recruiting
- Prostate cancer13 recruiting
- Chronic lymphocytic leukaemia12 recruiting
- Endometrial cancer12 recruiting
- Head and neck cancer11 recruiting
- Obesity10 recruiting
- Ulcerative colitis10 recruiting
- High blood pressure9 recruiting
- Acute myeloid leukaemia8 recruiting
- Heart failure8 recruiting
- Type 2 diabetes8 recruiting
- Melanoma7 recruiting
- Stroke7 recruiting
- Triple-negative breast cancer7 recruiting
- Acute lymphoblastic leukaemia6 recruiting
- Alzheimer disease6 recruiting
- Atrial fibrillation6 recruiting
- Follicular lymphoma6 recruiting
- Lupus (SLE)6 recruiting
- Sarcoma6 recruiting
- Cervical cancer5 recruiting
- Chronic kidney disease5 recruiting
- Diffuse large B-cell lymphoma5 recruiting
- Myeloproliferative neoplasms5 recruiting
- Pulmonary arterial hypertension5 recruiting
- Thyroid cancer5 recruiting
- Alopecia areata4 recruiting
- Fatty liver disease (MASLD/MASH)4 recruiting
- Immune thrombocytopenia (ITP)4 recruiting
- Amyloidosis3 recruiting
- Brain metastases3 recruiting
- Dermatomyositis and polymyositis (myositis)3 recruiting
- Duchenne muscular dystrophy3 recruiting
- IgA nephropathy3 recruiting
- Insomnia3 recruiting
- Liver cirrhosis3 recruiting
- Myelodysplastic syndromes3 recruiting
- Neuroendocrine tumours3 recruiting
- Parkinson disease3 recruiting
- Aortic aneurysm2 recruiting
- CIDP (chronic inflammatory demyelinating polyneuropathy)2 recruiting
- Congenital heart disease2 recruiting
- Deep vein thrombosis and pulmonary embolism2 recruiting
- Depression2 recruiting
- Epilepsy2 recruiting
- Glioblastoma2 recruiting
- Huntington's disease2 recruiting
- Idiopathic pulmonary fibrosis2 recruiting
- Kidney cancer2 recruiting
- Mantle cell lymphoma2 recruiting
- Migraine2 recruiting
- Multiple system atrophy2 recruiting
- Osteoarthritis2 recruiting
- Polycystic kidney disease2 recruiting
- Primary biliary cholangitis2 recruiting
- Psoriasis2 recruiting
- Systemic sclerosis (scleroderma)2 recruiting
- ALS (motor neurone disease)1 recruiting
- Ankylosing spondylitis1 recruiting
- Aortic stenosis1 recruiting
- Asthma1 recruiting
- Brain aneurysm1 recruiting
- Bronchiectasis1 recruiting
- Chronic spontaneous urticaria1 recruiting
- COPD1 recruiting
- Cushing's syndrome1 recruiting
- Endometriosis1 recruiting
- Hearing loss1 recruiting
- Hepatitis B1 recruiting
- Hodgkin lymphoma1 recruiting
- Lewy body dementia1 recruiting
- Macular degeneration1 recruiting
- Meningioma1 recruiting
- Mesothelioma1 recruiting
- Myotonic dystrophy1 recruiting
- Nephrotic syndrome1 recruiting
- Obstructive sleep apnoea1 recruiting
- Peripheral artery disease1 recruiting
- Pituitary tumours1 recruiting
- Rheumatoid arthritis1 recruiting
- Schizophrenia1 recruiting
- Spinal muscular atrophy1 recruiting
- Tuberculosis1 recruiting
- Turner syndrome1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
Sleep Efficacy Randomized Evaluation of a Novel Digital Therapeutic for Insomnia
Completed
Completed
Clinical Validation of Vital-PICASO for Predicting Cardiac Arrest Within 24 Hours
Completed
Terminated
Streamlining Radioembolization for Intrahepatic Cholangiocarcinoma
Completed
Recruiting
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Completed
Ultrasound-Based Estimation of Hepatic Steatosis in Pediatric MASLD
Terminated
Completed
Completed
A Study to Evaluate the Efficacy and Safety of Daridorexant in Participants With Insomnia Disorder
Completed
Terminated
A Study of ZW171 in Participants With Advanced or Metastatic Mesothelin-expressing Cancers
Completed
Completed
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age
Terminated
Completed
Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy
Completed
Recruiting
Completed
Completed
Completed
Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer
Completed
Terminated
Recruiting
Completed
Completed
JARDIANCE® Post Marketing Surveillance in Korean Patients With Chronic Kidney Disease (CKD)
Completed
Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Self-administered tDCS for Improving Single- and Dual-task Gait in Patients With PD
Completed
The Success of Lumbar Sympathetic Ganglion Block Using Lower Extremity Perfusion Index
Terminated
Completed
Completed
Completed
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)
Recruiting
Completed
Effect of Left Posterior Pericardiotomy for the Prevention of POAF
Completed
A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults
Completed
Completed
Completed
Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)
Completed
Completed
Terminated
Showing 50 of 367.
Registry name variants (150)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Seoul National University Hospital
Seoul, 03080
935 trials
Seoul National University Hospital
Jongno-gu, Seoul 03080
5 trials
Seoul National University Hospital (SNUH)
Seoul, 3080
4 trials
Seoul National University Hospital (Site 1000)
Seoul, 03080
3 trials
Seoul National University Hospital (Site 2301)
Seoul, 03080
3 trials
Contact: Study Coordinator
NCT07318558A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Contact: Study Coordinator
Contact: Study Coordinator
Seoul National University Hospital (Site 2803)
Seoul, 03080
3 trials
Contact: Study Coordinator
Seoul National University Hospital (Site 3001)
Seoul, 03080
3 trials
Seoul National University Hospital
Soeul
2 trials
Seoul National University Hospital
Suwon, 3080
2 trials
Seoul National University Hospital - Department of Internal
Seoul, 03080
2 trials
Seoul National University Hospital / Department of Internal Medicine
Seoul, 03080
2 trials
Seoul National University Hospital_Endocrinology
Seoul, 03080
2 trials
Contact: Novo Nordisk
Seoul National University Hospital (Site 0800)
Seoul, 03080
2 trials
Seoul National University Hospital (Site 1302)
Seoul, 03080
2 trials
Seoul National University Hospital (Site 1352)
Seoul, 03080
2 trials
Seoul National University Hospital (Site 2302)
Seoul, 03080
2 trials
4100008 - Seoul National University Hospital
Seoul, 03080
1 trial
Seoul National University Hospital
Seoul, 03080
1 trial
Seoul National University Hosp
Seoul, 110-744
1 trial
Seoul National University Hospital
Bundang-gu, Seongnam-si, Gyeonggido 13620
1 trial
NCT05580562ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
Contact: Tae Min Kim
Seoul National University Hospital
Cheonan
1 trial
Seoul National University Hospital
Ihwa-dong
1 trial
Seoul National University Hospital
Jongno-gu, Seoul, 03080
1 trial
Seoul National University Hospital
Junggu, 03080
1 trial
Seoul National University Hospital
Seongnam, Seoul
1 trial
NCT04779320A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Contact: Jin Soo Moon (principal investigator)
Seoul National University Hospital (b)
Seoul, 03080
1 trial
Seoul National University Hospital_Cardiology
Seoul, 03080
1 trial
Contact: Novo Nordisk
Seoul National University Hospital, Clinical Pharmacy
Seoul, 03080
1 trial
Seoul National University Hospital - Department of Hematology-Oncology
Seoul, 03080
1 trial
Seoul National University Hospital, Department of Obstetrics & Gynecology
Seoul, 110-744
1 trial
NCT03438474Endometrial Cancer Lymphadenectomy Trial
Contact: Jae Weon Kim, Professor MD
Seoul National University Hospital_Family Medicine
Seoul, 03080
1 trial
Seoul National University Hospital
Seoul, 03080
1 trial
Seoul National University Hospital
Seoul, 03080
1 trial
Seoul National University Hospital
Seoul, 03080
1 trial
Seoul National University Hospital
Seoul, 03080
1 trial
Seoul National University Hospital
Seoul, 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
NCT04777994Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Contact: Nicole Director Clinical Operations
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi 03080
1 trial
Seoul National University Hospital, Internal Medicine
Seoul
1 trial
Seoul National University Hospital - Nephrology
Seoul, 03080
1 trial
Seoul National University Hospital, Seoul, 03080
Seoul
1 trial
Seoul National University Hospital (Site 0007)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 0030)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 0074)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 0161)
Seoul, 03080
1 trial
Contact: Study Coordinator
Seoul National University Hospital (Site 0191)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 0201)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 0302)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 0312)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 0400)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 0462)
Seoul, Seoul-teukbyeolsi [Seoul] 03080
1 trial
Seoul National University Hospital (Site 0554)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 0600)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 0653)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 0706)
Seoul, 03080
1 trial
Contact: Study Coordinator
Seoul National University Hospital (Site 0801)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 0802)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 0875)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 0950)
Seoul, 03080
1 trial
Seoul National University Hospital - Site #107
Seoul, Seoul Teugbyeolsi 3080
1 trial
Seoul National University Hospital (Site 1101)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 1103)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 1300)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 1326)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 1351)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 1402)
Seoul, 03080
1 trial
Contact: Study Coordinator
Seoul National University Hospital (Site 1600)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 1602)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 1701)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 1801)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 1806)
Seoul, 03080
1 trial
Contact: Study Coordinator
Seoul National University Hospital (Site 2000)
Seoul, 03080
1 trial
NCT06843447A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003).
Contact: Study Coordinator
Seoul National University Hospital (Site 2101)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 2303)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 2403)
Seoul, 03080
1 trial
Seoul National University Hospital (Site # 2701)
Seoul, 3080
1 trial
Contact: Principal Investigator
Seoul National University Hospital (Site 2703)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 3005)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 3100)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 3102)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 3403)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 3502)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 3557)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 3607)
Seoul, 03080
1 trial
Contact: Study Coordinator
Seoul National University Hospital - Site 410-002
Seoul, 03080
1 trial
Seoul National University Hospital (Site 4101)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 4201)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 5100)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 5200)
Seoul, 03080
1 trial
Seoul National University Hospital (Site 5202)
Seoul, 03080
1 trial
Contact: Study Coordinator
Conditions
Diseases this institution publishes on or runs trials for.
- Liver and biliary tract cancer111 works · 72 trials
- Lung cancer93 works · 147 trials
- Atrial fibrillation81 works · 15 trials
- Gastric and oesophageal cancer80 works · 64 trials
- Colorectal cancer66 works · 73 trials
- Chronic kidney disease64 works · 21 trials
- Pancreatic cancer34 works · 42 trials
- Osteoarthritis32 works · 7 trials
- Coronary artery disease31 works · 31 trials
- Ovarian cancer29 works · 55 trials
- Triple-negative breast cancer25 works · 19 trials
- Glioblastoma23 works · 6 trials
- Multiple myeloma22 works · 40 trials
- Glaucoma21 works · 2 trials
- Osteoporosis20 works · 0 trials
- Metastatic breast cancer20 works · 55 trials
- Macular degeneration19 works · 6 trials
- Migraine19 works · 7 trials
- Insomnia19 works · 7 trials
- Thyroid cancer17 works · 13 trials
- Obstructive sleep apnoea16 works · 3 trials
- Diabetic eye disease15 works · 1 trial
- Hypertrophic cardiomyopathy11 works · 0 trials
- Neuroendocrine tumours11 works · 6 trials
- Idiopathic pulmonary fibrosis11 works · 7 trials
- Pituitary tumours11 works · 1 trial
- IgA nephropathy10 works · 7 trials
- Meningioma10 works · 1 trial
- Myeloproliferative neoplasms9 works · 19 trials
- Diffuse large B-cell lymphoma9 works · 24 trials
Institution data: ROR 01z4nnt86 (CC0-1.0)Updated 15 Nov 2026